RenovaCare (RenovaCare) Float Percentage Of Total Shares Outstanding : 19.04% (As of May. 14, 2024)

View and export this data going back to . Start your Free Trial

What is RenovaCare Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, RenovaCare's float shares is 16.64 Mil. RenovaCare's total shares outstanding is 87.35 Mil. RenovaCare's float percentage of total shares outstanding is 19.04%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, RenovaCare's Insider Ownership is 56.71%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, RenovaCare's Institutional Ownership is 0.00%.

RenovaCare Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

RenovaCare's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding	=	Float Shares	/	Total Shares Outstanding
	=	16.64	/	87.35
	=	19.04%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RenovaCare (RenovaCare) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » RenovaCare Inc (OTCPK:RCAR) » Definitions » Float Percentage Of Total Shares Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

9375 East Shea Boulvard, Suite 107-A, Scottsdale, AZ, USA, 85260

Website

https://www.renovacareinc.com

RenovaCare Inc is a biotechnology company focusing on the acquisition, research, development and commercialization of autologous cellular therapies that can be used for medical and aesthetic applications. The company's initial products under development target skin. It offers treatment methodology for cell isolation for the regeneration of human skin cells, along with a medical-grade liquid spraying device and associated equipment (the SkinGun). RenovaCare is evaluating the efficacy and potential of SkinGun, in combination with a cell isolation method, in the treatment of tissue that has been subject to severe trauma. Geographically all the activities are functioned through the region of United States.

Executives

Patsy Trisler	officer: Vice President	430 PARK AVENUE, SUITE 702, NEW YORK NY 10022
Thomas Bold	officer: President & CEO	430 PARK AVENUE, SUITE 702, NEW YORK NY 10022
Joseph Sierchio	director	430 PARK AVENUE, SUITE 702, NEW YORK NY 10022
Kenneth Kirkland	director	430 PARK AVENUE, SUITE 702, NEW YORK NY 10022
Rhonda Beth Rosen	director, officer: President & CEO	43 DICKINSON ROAD, BASKING RIDGE NJ 07920
1420525 Alberta Ltd.	10 percent owner	1628 WEST 1ST AVENUE, SUITE 216, VANCOUVER A1 V6J1G1
David E Jenkins	director	406 NORTH HERMOSA DRIVE, PALM SPRINGS CA 92262
Antonino G Cacace	director, officer: President	CRUD-Y-GWYNT, CASWELL BAY, SWANSEA X0 SA3 3BU
Jeet Sidhu	director	5667 SUNRISE CRESCENT WEST, SURREY, BC A1 V3S 7M4
Derek Cooper	officer: President/ CEO
Frank J Fabio	officer: CFO/Sec.(Resigned 1/9/2009)	670 BROADWAY, MASSAPEQUA NY 11758
Christian F Hudson	director	33 CHURCHILL ROAD, TENAFLY NJ 07670
Harmel S Rayat	director, 10 percent owner	700 - 688 WEST HASTINGS STREET, VANCOUVER A1 V6B 1P1
Stanley Wong	officer: President/CEO
Terri Dumoulin	director, officer: Secretary/Treasurer